AILV yields 8.76% · MRK yields 3.25%● Live data
📍 AILV pulled ahead of the other in Year 1
Combined, AILV + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AILV + MRK for your $10,000?
The fund is an actively-managed ETF that invests primarily in equity securities of large capitalization companies, with a focus on value stocks. Under normal circumstances, the fund will invest at least 80% of its net assets, plus borrowings for investment purposes, in the common stocks of large capitalization companies. These companies have market capitalizations in the range of companies in the Russell 1000 Value Index at the time of purchase. The fund is non-diversified.
Full AILV Calculator →Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.